Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation-Reference-Cited by-同舟云学术

Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation

Published:2019-04 Issue:3 Volume:27 Page:690-698.e4
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Vara-Ciruelos Diana,Dandapani Madhumita,Russell Fiona M.,Grzes Katarzyna M.,Atrih Abdelmadjid,Foretz Marc,Viollet Benoit,Lamont Douglas J.,Cantrell Doreen A.,Hardie D. Grahame

Funder

Cancer Research UK

Wellcome Trust

Boehringer-Ingelheim

GlaxoSmithKline

Merck Serono

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference28 articles.

1. LKB1-dependent signaling pathways;Alessi;Annu. Rev. Biochem.,2006

2. Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo;Algire;Oncogene,2011

3. AMPK re-activation suppresses hepatic steatosis but its downregulation does not promote fatty liver development;Boudaba;EBioMedicine,2018

4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding;Bradford;Anal. Biochem.,1976

5. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria;Bridges;Biochem. J.,2014

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Matrine induces autophagic cell death by triggering ROS/AMPK/mTOR axis and apoptosis in multiple myeloma;Biomedicine & Pharmacotherapy;2024-06

2. Impact of metformin on melanoma: a meta-analysis and systematic review;Frontiers in Oncology;2024-05-23

3. Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach;Biomedicines;2024-01-18

4. BAY-3827 and SBI-0206965: Potent AMPK Inhibitors That Paradoxically Increase Thr172 Phosphorylation;International Journal of Molecular Sciences;2023-12-29

5. Repurposing Metabolic Inhibitors in the Treatment of Colon Adenocarcinoma Patient-Derived Models;Cells;2023-12-18